HEADER CYTOKINE 05-OCT-20 7AL7 TITLE THE CRYSTAL STRUCTURE OF HUMAN IL-18 IN COMPLEX WITH HUMAN IL-18 TITLE 2 BINDING PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-18-BINDING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: IL-18BP,TADEKINIG-ALFA; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: THE FINAL PROTEIN SEQUENCE USED FOR CRYSTALLIZATION COMPND 7 STARTS AT T30 AND ENDS AT D170. THE N-TERMINAL RTPMU SIGNAL SEQUENCE COMPND 8 IS CLEAVED DURING EXPRESSION. THE C-TERMINAL AVI-HIS TAG WAS CLEAVED COMPND 9 BY CASPASE-3 AFTER THE DEVD SITE. IN REFERENCE TO THE NATIVE COMPND 10 SEQUENCE, THE FINAL PROTEIN SEQUENCE STARTS AT Q63 AND ENDS AT G194, COMPND 11 AS IT LACKS AN N-TERMINAL REGION FROM T31 TO K62.; COMPND 12 MOL_ID: 2; COMPND 13 MOLECULE: GLUTATHIONE S-TRANSFERASE CLASS-MU 26 KDA ISOZYME, COMPND 14 INTERLEUKIN-18; COMPND 15 CHAIN: B; COMPND 16 SYNONYM: GST 26,SJ26 ANTIGEN,SJGST,IL-18,IBOCTADEKIN,INTERFERON COMPND 17 GAMMA-INDUCING FACTOR,IFN-GAMMA-INDUCING FACTOR,INTERLEUKIN-1 GAMMA, COMPND 18 IL-1 GAMMA; COMPND 19 EC: 2.5.1.18; COMPND 20 ENGINEERED: YES; COMPND 21 OTHER_DETAILS: THE PROTEIN WAS EXPRESSED AS A HIS-GST FUSION WHICH COMPND 22 WAS CLEAVED AFTER THE DEVD SITE USING CASPASEA-3. THUS, THE FINAL COMPND 23 PROTEIN SEQUENCE USED FOR CRYSTALLIZATION STARTS AT Y234 AND ENDS AT COMPND 24 D390. IN REFERENCE TO THE NATIVE SEQUENCE, THE FINAL PROTEIN SEQUENCE COMPND 25 STARTS AT Y37 AND ENDS AT D193,THE PROTEIN WAS EXPRESSED AS A HIS-GST COMPND 26 FUSION WHICH WAS CLEAVED AFTER THE DEVD SITE USING CASPASEA-3. THUS, COMPND 27 THE FINAL PROTEIN SEQUENCE USED FOR CRYSTALLIZATION STARTS AT Y234 COMPND 28 AND ENDS AT D390. IN REFERENCE TO THE NATIVE SEQUENCE, THE FINAL COMPND 29 PROTEIN SEQUENCE STARTS AT Y37 AND ENDS AT D193,THE PROTEIN WAS COMPND 30 EXPRESSED AS A HIS-GST FUSION WHICH WAS CLEAVED AFTER THE DEVD SITE COMPND 31 USING CASPASEA-3. THUS, THE FINAL PROTEIN SEQUENCE USED FOR COMPND 32 CRYSTALLIZATION STARTS AT Y234 AND ENDS AT D390. IN REFERENCE TO THE COMPND 33 NATIVE SEQUENCE, THE FINAL PROTEIN SEQUENCE STARTS AT Y37 AND ENDS AT COMPND 34 D193,THE PROTEIN WAS EXPRESSED AS A HIS-GST FUSION WHICH WAS CLEAVED COMPND 35 AFTER THE DEVD SITE USING CASPASEA-3. THUS, THE FINAL PROTEIN COMPND 36 SEQUENCE USED FOR CRYSTALLIZATION STARTS AT Y234 AND ENDS AT D390. IN COMPND 37 REFERENCE TO THE NATIVE SEQUENCE, THE FINAL PROTEIN SEQUENCE STARTS COMPND 38 AT Y37 AND ENDS AT D193,THE PROTEIN WAS EXPRESSED AS A HIS-GST FUSION COMPND 39 WHICH WAS CLEAVED AFTER THE DEVD SITE USING CASPASEA-3. THUS, THE COMPND 40 FINAL PROTEIN SEQUENCE USED FOR CRYSTALLIZATION STARTS AT Y234 AND COMPND 41 ENDS AT D390. IN REFERENCE TO THE NATIVE SEQUENCE, THE FINAL PROTEIN COMPND 42 SEQUENCE STARTS AT Y37 AND ENDS AT D193,THE PROTEIN WAS EXPRESSED AS COMPND 43 A HIS-GST FUSION WHICH WAS CLEAVED AFTER THE DEVD SITE USING COMPND 44 CASPASEA-3. THUS, THE FINAL PROTEIN SEQUENCE USED FOR CRYSTALLIZATION COMPND 45 STARTS AT Y234 AND ENDS AT D390. IN REFERENCE TO THE NATIVE SEQUENCE, COMPND 46 THE FINAL PROTEIN SEQUENCE STARTS AT Y37 AND ENDS AT D193,THE PROTEIN COMPND 47 WAS EXPRESSED AS A HIS-GST FUSION WHICH WAS CLEAVED AFTER THE DEVD COMPND 48 SITE USING CASPASEA-3. THUS, THE FINAL PROTEIN SEQUENCE USED FOR COMPND 49 CRYSTALLIZATION STARTS AT Y234 AND ENDS AT D390. IN REFERENCE TO THE COMPND 50 NATIVE SEQUENCE, THE FINAL PROTEIN SEQUENCE STARTS AT Y37 AND ENDS AT COMPND 51 D193,THE PROTEIN WAS EXPRESSED AS A HIS-GST FUSION WHICH WAS CLEAVED COMPND 52 AFTER THE DEVD SITE USING CASPASEA-3. THUS, THE FINAL PROTEIN COMPND 53 SEQUENCE USED FOR CRYSTALLIZATION STARTS AT Y234 AND ENDS AT D390. IN COMPND 54 REFERENCE TO THE NATIVE SEQUENCE, THE FINAL PROTEIN SEQUENCE STARTS COMPND 55 AT Y37 AND ENDS AT D193 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IL18BP; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293S MGAT -/-; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PHLSEC; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: SCHISTOSOMA JAPONICUM, HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: BLOOD FLUKE, HUMAN; SOURCE 14 ORGANISM_TAXID: 6182, 9606; SOURCE 15 GENE: IL18, IGIF, IL1F4; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 19 EXPRESSION_SYSTEM_PLASMID: PET-42 KEYWDS CYTOKINE, DECOY RECEPTOR, ANTAGONIST, COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.DETRY,J.ANDRIES,Y.BLOCH,D.CLANCY,S.N.SAVVIDES REVDAT 4 31-JAN-24 7AL7 1 REMARK REVDAT 3 25-MAY-22 7AL7 1 JRNL REVDAT 2 27-APR-22 7AL7 1 JRNL REVDAT 1 20-APR-22 7AL7 0 JRNL AUTH S.DETRY,J.ANDRIES,Y.BLOCH,C.GABAY,D.M.CLANCY,S.N.SAVVIDES JRNL TITL STRUCTURAL BASIS OF HUMAN IL-18 SEQUESTRATION BY THE DECOY JRNL TITL 2 RECEPTOR IL-18 BINDING PROTEIN IN INFLAMMATION AND TUMOR JRNL TITL 3 IMMUNITY. JRNL REF J.BIOL.CHEM. V. 298 01908 2022 JRNL REFN ESSN 1083-351X JRNL PMID 35398099 JRNL DOI 10.1016/J.JBC.2022.101908 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.39 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 26368 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.010 REMARK 3 FREE R VALUE TEST SET COUNT : 2640 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 59.3860 - 4.8039 0.99 1315 149 0.1809 0.1779 REMARK 3 2 4.8039 - 3.8132 0.99 1291 143 0.1321 0.1622 REMARK 3 3 3.8132 - 3.3312 1.00 1285 134 0.1764 0.2046 REMARK 3 4 3.3312 - 3.0267 1.00 1255 151 0.1880 0.1987 REMARK 3 5 3.0267 - 2.8097 0.99 1264 142 0.2166 0.2153 REMARK 3 6 2.8097 - 2.6441 0.99 1258 134 0.2159 0.2277 REMARK 3 7 2.6441 - 2.5117 0.99 1256 136 0.2298 0.2847 REMARK 3 8 2.5117 - 2.4023 0.99 1238 156 0.2509 0.3123 REMARK 3 9 2.4023 - 2.3098 0.99 1289 127 0.2536 0.3424 REMARK 3 10 2.3098 - 2.2301 0.99 1237 133 0.2760 0.2889 REMARK 3 11 2.2301 - 2.1604 0.98 1231 146 0.2821 0.3341 REMARK 3 12 2.1604 - 2.0986 0.98 1243 146 0.3006 0.3245 REMARK 3 13 2.0986 - 2.0434 0.98 1227 136 0.3143 0.3753 REMARK 3 14 2.0434 - 1.9935 0.98 1255 131 0.3248 0.3778 REMARK 3 15 1.9935 - 1.9482 0.97 1219 133 0.3382 0.4014 REMARK 3 16 1.9482 - 1.9068 0.98 1240 137 0.3710 0.4629 REMARK 3 17 1.9068 - 1.8686 0.97 1212 146 0.4576 0.4681 REMARK 3 18 1.8686 - 1.8333 0.97 1230 125 0.5089 0.5928 REMARK 3 19 1.8333 - 1.8010 0.95 1183 135 0.5534 0.5871 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 39.860 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7AL7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1292111534. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAY-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, EMBL C/O DESY REMARK 200 BEAMLINE : P14 (MX2) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9762 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS VMAR 15, 2019 REMARK 200 DATA SCALING SOFTWARE : XSCALE VMAR 15, 2019, STARANISO REMARK 200 V1.0.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26507 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 59.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.6700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.91 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.750 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER V2.8 REMARK 200 STARTING MODEL: 3F62 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M CALCIUM ACETATE HYDRATE, 0.1 M REMARK 280 SODIUM CACODYLATE TRIHYDRATE PH 6.5, 18% W/V POLYETHYLENE GLYCOL REMARK 280 8000, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 54.90750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.26000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 54.90750 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.26000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 61 REMARK 465 GLY A 62 REMARK 465 GLY A 171 REMARK 465 LEU A 172 REMARK 465 ARG A 173 REMARK 465 ALA A 174 REMARK 465 THR A 175 REMARK 465 LEU A 176 REMARK 465 PRO A 177 REMARK 465 PRO A 178 REMARK 465 THR A 179 REMARK 465 GLN A 180 REMARK 465 GLU A 181 REMARK 465 ALA A 182 REMARK 465 LEU A 183 REMARK 465 PRO A 184 REMARK 465 SER A 185 REMARK 465 SER A 186 REMARK 465 HIS A 187 REMARK 465 SER A 188 REMARK 465 SER A 189 REMARK 465 PRO A 190 REMARK 465 GLN A 191 REMARK 465 GLN A 192 REMARK 465 GLN A 193 REMARK 465 GLY A 194 REMARK 465 GLY A 195 REMARK 465 THR A 196 REMARK 465 SER A 197 REMARK 465 ASP A 198 REMARK 465 GLU A 199 REMARK 465 VAL A 200 REMARK 465 ASP A 201 REMARK 465 GLY A 202 REMARK 465 GLY A 203 REMARK 465 SER A 204 REMARK 465 GLY A 205 REMARK 465 GLY A 206 REMARK 465 SER A 207 REMARK 465 GLY A 208 REMARK 465 LEU A 209 REMARK 465 ASN A 210 REMARK 465 ASP A 211 REMARK 465 ILE A 212 REMARK 465 PHE A 213 REMARK 465 GLU A 214 REMARK 465 ALA A 215 REMARK 465 GLN A 216 REMARK 465 LYS A 217 REMARK 465 ILE A 218 REMARK 465 GLU A 219 REMARK 465 TRP A 220 REMARK 465 HIS A 221 REMARK 465 GLU A 222 REMARK 465 GLY A 223 REMARK 465 ARG A 224 REMARK 465 THR A 225 REMARK 465 LYS A 226 REMARK 465 HIS A 227 REMARK 465 HIS A 228 REMARK 465 HIS A 229 REMARK 465 HIS A 230 REMARK 465 HIS A 231 REMARK 465 HIS A 232 REMARK 465 MET B -196 REMARK 465 HIS B -195 REMARK 465 HIS B -194 REMARK 465 HIS B -193 REMARK 465 HIS B -192 REMARK 465 HIS B -191 REMARK 465 HIS B -190 REMARK 465 SER B -189 REMARK 465 PRO B -188 REMARK 465 ILE B -187 REMARK 465 LEU B -186 REMARK 465 GLY B -185 REMARK 465 TYR B -184 REMARK 465 TRP B -183 REMARK 465 LYS B -182 REMARK 465 ILE B -181 REMARK 465 LYS B -180 REMARK 465 GLY B -179 REMARK 465 LEU B -178 REMARK 465 VAL B -177 REMARK 465 GLN B -176 REMARK 465 PRO B -175 REMARK 465 THR B -174 REMARK 465 ARG B -173 REMARK 465 LEU B -172 REMARK 465 LEU B -171 REMARK 465 LEU B -170 REMARK 465 GLU B -169 REMARK 465 TYR B -168 REMARK 465 LEU B -167 REMARK 465 GLU B -166 REMARK 465 GLU B -165 REMARK 465 LYS B -164 REMARK 465 TYR B -163 REMARK 465 GLU B -162 REMARK 465 GLU B -161 REMARK 465 HIS B -160 REMARK 465 LEU B -159 REMARK 465 TYR B -158 REMARK 465 GLU B -157 REMARK 465 ARG B -156 REMARK 465 ASP B -155 REMARK 465 GLU B -154 REMARK 465 GLY B -153 REMARK 465 ASP B -152 REMARK 465 LYS B -151 REMARK 465 TRP B -150 REMARK 465 ARG B -149 REMARK 465 ASN B -148 REMARK 465 LYS B -147 REMARK 465 LYS B -146 REMARK 465 PHE B -145 REMARK 465 GLU B -144 REMARK 465 LEU B -143 REMARK 465 GLY B -142 REMARK 465 LEU B -141 REMARK 465 GLU B -140 REMARK 465 PHE B -139 REMARK 465 PRO B -138 REMARK 465 ASN B -137 REMARK 465 LEU B -136 REMARK 465 PRO B -135 REMARK 465 TYR B -134 REMARK 465 TYR B -133 REMARK 465 ILE B -132 REMARK 465 ASP B -131 REMARK 465 GLY B -130 REMARK 465 ASP B -129 REMARK 465 VAL B -128 REMARK 465 LYS B -127 REMARK 465 LEU B -126 REMARK 465 THR B -125 REMARK 465 GLN B -124 REMARK 465 SER B -123 REMARK 465 MET B -122 REMARK 465 ALA B -121 REMARK 465 ILE B -120 REMARK 465 ILE B -119 REMARK 465 ARG B -118 REMARK 465 TYR B -117 REMARK 465 ILE B -116 REMARK 465 ALA B -115 REMARK 465 ASP B -114 REMARK 465 LYS B -113 REMARK 465 HIS B -112 REMARK 465 ASN B -111 REMARK 465 MET B -110 REMARK 465 LEU B -109 REMARK 465 GLY B -108 REMARK 465 GLY B -107 REMARK 465 CYS B -106 REMARK 465 PRO B -105 REMARK 465 LYS B -104 REMARK 465 GLU B -103 REMARK 465 ARG B -102 REMARK 465 ALA B -101 REMARK 465 GLU B -100 REMARK 465 ILE B -99 REMARK 465 SER B -98 REMARK 465 MET B -97 REMARK 465 LEU B -96 REMARK 465 GLU B -95 REMARK 465 GLY B -94 REMARK 465 ALA B -93 REMARK 465 VAL B -92 REMARK 465 LEU B -91 REMARK 465 ASP B -90 REMARK 465 ILE B -89 REMARK 465 ARG B -88 REMARK 465 TYR B -87 REMARK 465 GLY B -86 REMARK 465 VAL B -85 REMARK 465 SER B -84 REMARK 465 ARG B -83 REMARK 465 ILE B -82 REMARK 465 ALA B -81 REMARK 465 TYR B -80 REMARK 465 SER B -79 REMARK 465 LYS B -78 REMARK 465 ASP B -77 REMARK 465 PHE B -76 REMARK 465 GLU B -75 REMARK 465 THR B -74 REMARK 465 LEU B -73 REMARK 465 LYS B -72 REMARK 465 VAL B -71 REMARK 465 ASP B -70 REMARK 465 PHE B -69 REMARK 465 LEU B -68 REMARK 465 SER B -67 REMARK 465 LYS B -66 REMARK 465 LEU B -65 REMARK 465 PRO B -64 REMARK 465 GLU B -63 REMARK 465 MET B -62 REMARK 465 LEU B -61 REMARK 465 LYS B -60 REMARK 465 MET B -59 REMARK 465 PHE B -58 REMARK 465 GLU B -57 REMARK 465 ASP B -56 REMARK 465 ARG B -55 REMARK 465 LEU B -54 REMARK 465 CYS B -53 REMARK 465 HIS B -52 REMARK 465 LYS B -51 REMARK 465 THR B -50 REMARK 465 TYR B -49 REMARK 465 LEU B -48 REMARK 465 ASN B -47 REMARK 465 GLY B -46 REMARK 465 ASP B -45 REMARK 465 HIS B -44 REMARK 465 VAL B -43 REMARK 465 THR B -42 REMARK 465 HIS B -41 REMARK 465 PRO B -40 REMARK 465 ASP B -39 REMARK 465 PHE B -38 REMARK 465 MET B -37 REMARK 465 LEU B -36 REMARK 465 TYR B -35 REMARK 465 ASP B -34 REMARK 465 ALA B -33 REMARK 465 LEU B -32 REMARK 465 ASP B -31 REMARK 465 VAL B -30 REMARK 465 VAL B -29 REMARK 465 LEU B -28 REMARK 465 TYR B -27 REMARK 465 MET B -26 REMARK 465 ASP B -25 REMARK 465 PRO B -24 REMARK 465 MET B -23 REMARK 465 CYS B -22 REMARK 465 LEU B -21 REMARK 465 ASP B -20 REMARK 465 ALA B -19 REMARK 465 PHE B -18 REMARK 465 PRO B -17 REMARK 465 LYS B -16 REMARK 465 LEU B -15 REMARK 465 VAL B -14 REMARK 465 CYS B -13 REMARK 465 PHE B -12 REMARK 465 LYS B -11 REMARK 465 LYS B -10 REMARK 465 ARG B -9 REMARK 465 ILE B -8 REMARK 465 GLU B -7 REMARK 465 ALA B -6 REMARK 465 ILE B -5 REMARK 465 PRO B -4 REMARK 465 GLN B -3 REMARK 465 ILE B -2 REMARK 465 ASP B -1 REMARK 465 LYS B 0 REMARK 465 TYR B 1 REMARK 465 LEU B 2 REMARK 465 LYS B 3 REMARK 465 SER B 4 REMARK 465 SER B 5 REMARK 465 LYS B 6 REMARK 465 TYR B 7 REMARK 465 ILE B 8 REMARK 465 ALA B 9 REMARK 465 TRP B 10 REMARK 465 PRO B 11 REMARK 465 LEU B 12 REMARK 465 GLN B 13 REMARK 465 GLY B 14 REMARK 465 TRP B 15 REMARK 465 GLN B 16 REMARK 465 ALA B 17 REMARK 465 THR B 18 REMARK 465 PHE B 19 REMARK 465 GLY B 20 REMARK 465 GLY B 21 REMARK 465 GLY B 22 REMARK 465 ASP B 23 REMARK 465 HIS B 24 REMARK 465 PRO B 25 REMARK 465 PRO B 26 REMARK 465 LYS B 27 REMARK 465 SER B 28 REMARK 465 ASP B 29 REMARK 465 ARG B 30 REMARK 465 GLU B 31 REMARK 465 PHE B 32 REMARK 465 ASP B 33 REMARK 465 GLU B 34 REMARK 465 VAL B 35 REMARK 465 ASP B 36 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 103 O5 NAG A 301 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU B 41 -130.47 -114.25 REMARK 500 CSO B 104 -138.49 -110.65 REMARK 500 ARG B 167 -127.94 57.49 REMARK 500 REMARK 500 REMARK: NULL DBREF 7AL7 A 63 194 UNP O95998 I18BP_HUMAN 63 194 DBREF 7AL7 B -189 27 UNP P08515 GST26_SCHJA 2 218 DBREF 7AL7 B 36 193 UNP Q14116 IL18_HUMAN 36 193 SEQADV 7AL7 THR A 61 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLY A 62 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLY A 195 UNP O95998 EXPRESSION TAG SEQADV 7AL7 THR A 196 UNP O95998 EXPRESSION TAG SEQADV 7AL7 SER A 197 UNP O95998 EXPRESSION TAG SEQADV 7AL7 ASP A 198 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLU A 199 UNP O95998 EXPRESSION TAG SEQADV 7AL7 VAL A 200 UNP O95998 EXPRESSION TAG SEQADV 7AL7 ASP A 201 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLY A 202 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLY A 203 UNP O95998 EXPRESSION TAG SEQADV 7AL7 SER A 204 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLY A 205 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLY A 206 UNP O95998 EXPRESSION TAG SEQADV 7AL7 SER A 207 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLY A 208 UNP O95998 EXPRESSION TAG SEQADV 7AL7 LEU A 209 UNP O95998 EXPRESSION TAG SEQADV 7AL7 ASN A 210 UNP O95998 EXPRESSION TAG SEQADV 7AL7 ASP A 211 UNP O95998 EXPRESSION TAG SEQADV 7AL7 ILE A 212 UNP O95998 EXPRESSION TAG SEQADV 7AL7 PHE A 213 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLU A 214 UNP O95998 EXPRESSION TAG SEQADV 7AL7 ALA A 215 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLN A 216 UNP O95998 EXPRESSION TAG SEQADV 7AL7 LYS A 217 UNP O95998 EXPRESSION TAG SEQADV 7AL7 ILE A 218 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLU A 219 UNP O95998 EXPRESSION TAG SEQADV 7AL7 TRP A 220 UNP O95998 EXPRESSION TAG SEQADV 7AL7 HIS A 221 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLU A 222 UNP O95998 EXPRESSION TAG SEQADV 7AL7 GLY A 223 UNP O95998 EXPRESSION TAG SEQADV 7AL7 ARG A 224 UNP O95998 EXPRESSION TAG SEQADV 7AL7 THR A 225 UNP O95998 EXPRESSION TAG SEQADV 7AL7 LYS A 226 UNP O95998 EXPRESSION TAG SEQADV 7AL7 HIS A 227 UNP O95998 EXPRESSION TAG SEQADV 7AL7 HIS A 228 UNP O95998 EXPRESSION TAG SEQADV 7AL7 HIS A 229 UNP O95998 EXPRESSION TAG SEQADV 7AL7 HIS A 230 UNP O95998 EXPRESSION TAG SEQADV 7AL7 HIS A 231 UNP O95998 EXPRESSION TAG SEQADV 7AL7 HIS A 232 UNP O95998 EXPRESSION TAG SEQADV 7AL7 MET B -196 UNP P08515 INITIATING METHIONINE SEQADV 7AL7 HIS B -195 UNP P08515 EXPRESSION TAG SEQADV 7AL7 HIS B -194 UNP P08515 EXPRESSION TAG SEQADV 7AL7 HIS B -193 UNP P08515 EXPRESSION TAG SEQADV 7AL7 HIS B -192 UNP P08515 EXPRESSION TAG SEQADV 7AL7 HIS B -191 UNP P08515 EXPRESSION TAG SEQADV 7AL7 HIS B -190 UNP P08515 EXPRESSION TAG SEQADV 7AL7 SER B 28 UNP P08515 LINKER SEQADV 7AL7 ASP B 29 UNP P08515 LINKER SEQADV 7AL7 ARG B 30 UNP P08515 LINKER SEQADV 7AL7 GLU B 31 UNP P08515 LINKER SEQADV 7AL7 PHE B 32 UNP P08515 LINKER SEQADV 7AL7 ASP B 33 UNP P08515 LINKER SEQADV 7AL7 GLU B 34 UNP P08515 LINKER SEQADV 7AL7 VAL B 35 UNP P08515 LINKER SEQRES 1 A 172 THR GLY PCA CYS PRO ALA LEU GLU VAL THR TRP PRO GLU SEQRES 2 A 172 VAL GLU VAL PRO LEU ASN GLY THR LEU SER LEU SER CYS SEQRES 3 A 172 VAL ALA CYS SER ARG PHE PRO ASN PHE SER ILE LEU TYR SEQRES 4 A 172 TRP LEU GLY ASN GLY SER PHE ILE GLU HIS LEU PRO GLY SEQRES 5 A 172 ARG LEU TRP GLU GLY SER THR SER ARG GLU ARG GLY SER SEQRES 6 A 172 THR GLY THR GLN LEU CYS LYS ALA LEU VAL LEU GLU GLN SEQRES 7 A 172 LEU THR PRO ALA LEU HIS SER THR ASN PHE SER CYS VAL SEQRES 8 A 172 LEU VAL ASP PRO GLU GLN VAL VAL GLN ARG HIS VAL VAL SEQRES 9 A 172 LEU ALA GLN LEU TRP ALA GLY LEU ARG ALA THR LEU PRO SEQRES 10 A 172 PRO THR GLN GLU ALA LEU PRO SER SER HIS SER SER PRO SEQRES 11 A 172 GLN GLN GLN GLY GLY THR SER ASP GLU VAL ASP GLY GLY SEQRES 12 A 172 SER GLY GLY SER GLY LEU ASN ASP ILE PHE GLU ALA GLN SEQRES 13 A 172 LYS ILE GLU TRP HIS GLU GLY ARG THR LYS HIS HIS HIS SEQRES 14 A 172 HIS HIS HIS SEQRES 1 B 390 MET HIS HIS HIS HIS HIS HIS SER PRO ILE LEU GLY TYR SEQRES 2 B 390 TRP LYS ILE LYS GLY LEU VAL GLN PRO THR ARG LEU LEU SEQRES 3 B 390 LEU GLU TYR LEU GLU GLU LYS TYR GLU GLU HIS LEU TYR SEQRES 4 B 390 GLU ARG ASP GLU GLY ASP LYS TRP ARG ASN LYS LYS PHE SEQRES 5 B 390 GLU LEU GLY LEU GLU PHE PRO ASN LEU PRO TYR TYR ILE SEQRES 6 B 390 ASP GLY ASP VAL LYS LEU THR GLN SER MET ALA ILE ILE SEQRES 7 B 390 ARG TYR ILE ALA ASP LYS HIS ASN MET LEU GLY GLY CYS SEQRES 8 B 390 PRO LYS GLU ARG ALA GLU ILE SER MET LEU GLU GLY ALA SEQRES 9 B 390 VAL LEU ASP ILE ARG TYR GLY VAL SER ARG ILE ALA TYR SEQRES 10 B 390 SER LYS ASP PHE GLU THR LEU LYS VAL ASP PHE LEU SER SEQRES 11 B 390 LYS LEU PRO GLU MET LEU LYS MET PHE GLU ASP ARG LEU SEQRES 12 B 390 CYS HIS LYS THR TYR LEU ASN GLY ASP HIS VAL THR HIS SEQRES 13 B 390 PRO ASP PHE MET LEU TYR ASP ALA LEU ASP VAL VAL LEU SEQRES 14 B 390 TYR MET ASP PRO MET CYS LEU ASP ALA PHE PRO LYS LEU SEQRES 15 B 390 VAL CYS PHE LYS LYS ARG ILE GLU ALA ILE PRO GLN ILE SEQRES 16 B 390 ASP LYS TYR LEU LYS SER SER LYS TYR ILE ALA TRP PRO SEQRES 17 B 390 LEU GLN GLY TRP GLN ALA THR PHE GLY GLY GLY ASP HIS SEQRES 18 B 390 PRO PRO LYS SER ASP ARG GLU PHE ASP GLU VAL ASP TYR SEQRES 19 B 390 PHE GLY LYS LEU GLU SER LYS LEU SER VAL ILE ARG ASN SEQRES 20 B 390 LEU ASN ASP GLN VAL LEU PHE ILE ASP GLN GLY ASN ARG SEQRES 21 B 390 PRO LEU PHE GLU ASP MET THR ASP SER ASP CYS ARG ASP SEQRES 22 B 390 ASN ALA PRO ARG THR ILE PHE ILE ILE SER MET TYR LYS SEQRES 23 B 390 ASP SER GLN PRO ARG GLY MET ALA VAL THR ILE SER VAL SEQRES 24 B 390 LYS CSO GLU LYS ILE SER THR LEU SER CYS GLU ASN LYS SEQRES 25 B 390 ILE ILE SER PHE LYS GLU MET ASN PRO PRO ASP ASN ILE SEQRES 26 B 390 LYS ASP THR LYS SER ASP ILE ILE PHE PHE GLN ARG SER SEQRES 27 B 390 VAL PRO GLY HIS ASP ASN LYS MET GLN PHE GLU SER SER SEQRES 28 B 390 SER TYR GLU GLY TYR PHE LEU ALA CYS GLU LYS GLU ARG SEQRES 29 B 390 ASP LEU PHE LYS LEU ILE LEU LYS LYS GLU ASP GLU LEU SEQRES 30 B 390 GLY ASP ARG SER ILE MET PHE THR VAL GLN ASN GLU ASP MODRES 7AL7 PCA A 63 GLN MODIFIED RESIDUE MODRES 7AL7 CSO B 104 CYS MODIFIED RESIDUE HET PCA A 63 14 HET CSO B 104 12 HET NAG A 301 28 HET NAG A 302 28 HET NAG A 303 28 HETNAM PCA PYROGLUTAMIC ACID HETNAM CSO S-HYDROXYCYSTEINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 1 PCA C5 H7 N O3 FORMUL 2 CSO C3 H7 N O3 S FORMUL 3 NAG 3(C8 H15 N O6) FORMUL 6 HOH *130(H2 O) HELIX 1 AA1 GLU A 108 LEU A 110 5 3 HELIX 2 AA2 THR A 140 SER A 145 1 6 HELIX 3 AA3 LEU A 165 ALA A 170 1 6 HELIX 4 AA4 ASP B 73 ASN B 77 5 5 HELIX 5 AA5 ALA B 78 THR B 81 5 4 HELIX 6 AA6 CYS B 112 ILE B 116 5 5 HELIX 7 AA7 ASP B 182 MET B 186 5 5 SHEET 1 AA1 4 ALA A 66 THR A 70 0 SHEET 2 AA1 4 LEU A 82 SER A 90 -1 O VAL A 87 N GLU A 68 SHEET 3 AA1 4 THR A 128 LEU A 136 -1 O LEU A 136 N LEU A 82 SHEET 4 AA1 4 LEU A 114 GLU A 116 -1 N TRP A 115 O VAL A 135 SHEET 1 AA2 4 ALA A 66 THR A 70 0 SHEET 2 AA2 4 LEU A 82 SER A 90 -1 O VAL A 87 N GLU A 68 SHEET 3 AA2 4 THR A 128 LEU A 136 -1 O LEU A 136 N LEU A 82 SHEET 4 AA2 4 SER A 120 ARG A 123 -1 N GLU A 122 O GLN A 129 SHEET 1 AA3 4 SER A 105 PHE A 106 0 SHEET 2 AA3 4 ILE A 97 GLY A 102 -1 N GLY A 102 O SER A 105 SHEET 3 AA3 4 ASN A 147 VAL A 153 -1 O VAL A 151 N TYR A 99 SHEET 4 AA3 4 VAL A 158 VAL A 164 -1 O VAL A 159 N LEU A 152 SHEET 1 AA4 7 SER B 118 GLU B 121 0 SHEET 2 AA4 7 ILE B 107 SER B 111 -1 N SER B 111 O SER B 118 SHEET 3 AA4 7 MET B 96 LYS B 103 -1 N ILE B 100 O LEU B 110 SHEET 4 AA4 7 PHE B 83 ASP B 90 -1 N ILE B 84 O SER B 101 SHEET 5 AA4 7 PHE B 38 ARG B 49 -1 N SER B 46 O PHE B 83 SHEET 6 AA4 7 PHE B 137 SER B 141 0 SHEET 7 AA4 7 MET B 149 SER B 153 -1 O GLN B 150 N ARG B 140 SHEET 1 AA5 5 ASN B 127 ILE B 128 0 SHEET 2 AA5 5 PHE B 38 ARG B 49 -1 N PHE B 38 O ILE B 128 SHEET 3 AA5 5 PHE B 83 ASP B 90 -1 O PHE B 83 N SER B 46 SHEET 4 AA5 5 MET B 96 LYS B 103 -1 O SER B 101 N ILE B 84 SHEET 5 AA5 5 THR B 188 ASN B 191 0 SHEET 1 AA6 2 VAL B 55 ILE B 58 0 SHEET 2 AA6 2 PRO B 64 GLU B 67 -1 O GLU B 67 N VAL B 55 SHEET 1 AA7 2 TYR B 159 GLU B 166 0 SHEET 2 AA7 2 LEU B 169 LYS B 176 -1 O ILE B 173 N ALA B 162 SSBOND 1 CYS A 64 CYS A 89 1555 1555 2.08 SSBOND 2 CYS A 86 CYS A 150 1555 1555 1.99 SSBOND 3 CYS A 131 CYS B 74 1555 2555 2.21 LINK C PCA A 63 N CYS A 64 1555 1555 1.33 LINK ND2 ASN A 79 C1 NAG A 302 1555 1555 1.47 LINK ND2 ASN A 103 C1 NAG A 301 1555 1555 1.55 LINK ND2 ASN A 147 C1 NAG A 303 1555 1555 1.42 LINK C LYS B 103 N CSO B 104 1555 1555 1.34 LINK C CSO B 104 N GLU B 105 1555 1555 1.37 CISPEP 1 CYS A 64 PRO A 65 0 5.32 CRYST1 109.815 44.520 60.276 90.00 99.86 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009106 0.000000 0.001583 0.00000 SCALE2 0.000000 0.022462 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016839 0.00000 HETATM 1 N PCA A 63 20.691 -17.562 -4.940 1.00 63.10 N ANISOU 1 N PCA A 63 9839 5790 8346 1325 1448 333 N HETATM 2 CA PCA A 63 19.209 -17.342 -5.097 1.00 59.49 C ANISOU 2 CA PCA A 63 9508 5278 7817 984 1362 220 C HETATM 3 CB PCA A 63 18.470 -18.652 -4.819 1.00 70.04 C ANISOU 3 CB PCA A 63 11125 6343 9145 864 1467 227 C HETATM 4 CG PCA A 63 19.502 -19.753 -5.032 1.00 81.30 C ANISOU 4 CG PCA A 63 12691 7577 10624 1112 1679 266 C HETATM 5 CD PCA A 63 20.814 -19.022 -4.917 1.00 79.68 C ANISOU 5 CD PCA A 63 12196 7603 10476 1405 1643 363 C HETATM 6 OE PCA A 63 21.885 -19.619 -4.805 1.00 87.33 O ANISOU 6 OE PCA A 63 13146 8525 11510 1680 1771 469 O HETATM 7 C PCA A 63 18.725 -16.181 -4.230 1.00 50.33 C ANISOU 7 C PCA A 63 8115 4354 6656 932 1153 301 C HETATM 8 O PCA A 63 18.604 -15.081 -4.762 1.00 51.23 O ANISOU 8 O PCA A 63 8106 4621 6738 847 1060 218 O HETATM 9 H PCA A 63 21.099 -17.562 -5.728 1.00 75.73 H HETATM 10 HA PCA A 63 18.993 -17.099 -6.023 1.00 71.40 H HETATM 11 HB2 PCA A 63 17.710 -18.751 -5.426 1.00 84.07 H HETATM 12 HB3 PCA A 63 18.126 -18.657 -3.900 1.00 84.07 H HETATM 13 HG2 PCA A 63 19.395 -20.170 -5.914 1.00 97.58 H HETATM 14 HG3 PCA A 63 19.414 -20.455 -4.354 1.00 97.58 H